原文标题：Novavax: Deal agreed to 'fill and finish' 60 million doses in UK
原文连结：https://www.bbc.com/news/uk-england-tees-56570168
发布时间：2021/03/29
原文内容：
Tens of millions of doses of the Novavax vaccine will now be produced and packaged in the North East, the prime minister has announced.
Boris Johnson said a deal had been agreed with GlaxoSmithKline (GSK) to bottle 60 million doses at its facility in Barnard Castle.
GSK said it hoped the "fill and finish" process can begin as early as May.
In January, it was announced the vaccine would be manufactured at the Fujifilm plant in Stockton-on-Tees.
Novavax is currently being assessed by the Medicines and Healthcare products Regulatory Agency.
The biotech company behind it, also called Novavax, recently announced its vaccine was 86% effective against the Kent variant of Covid-19 and 96% effective in preventing cases caused by the original strain.
Mr Johnson said: "I'm delighted by GSK's investment, which shows the strength of UK manufacturing, and will further boost our vaccine rollout.
"The Vaccines Taskforce has worked hand in glove with business to successfully deliver vaccines to the whole of the UK, and this agreement will continue to support our approach.
"We remain on track to offer a first jab to all over 50s by 15 April, and all adults by the end of July, and I want to once again encourage everyone to come forward for a vaccine when you're called."
简单重点：：
鲍里斯·约翰逊(Boris Johnson)揭幕了新的英国疫苗工厂：政府与制药巨头葛兰素史克(GlaxoSmithKline)签署协议，将在达勒姆“补充和完成”6,000万剂诺瓦瓦克斯(Novavax )的新冠病毒疫苗，这将成为第五种获得批准的疫苗。
英国已经与美国公司签订了一项预先购买协议，购买了6,000万剂Novavax两针疫苗，足以让3,000万英国人完全接种。本月早些时候，诺瓦瓦克斯(Novavax)宣布，其疫苗在阻止症状性疾病方面的有效性为89%，并100%阻止了住院和死亡。
诺瓦瓦克斯将于未来几周向英国医疗监管机构提交晚期试验数据，预计将于5月获得批准。迄今为止，已经有三种疫苗被MHRA批准，分别由辉瑞、阿斯利康和Moderna生产，而由强生研发的第四种疫苗目前正在审查中。
心得/评论：
除了上面利好消息，
印度血清研究所称，与美国制药巨头Novavax联合开发的Covovax疫苗整体有效率为89%。
目前NOVAVAX疫苗未来趋势看涨。